mtas: both sides now!
DESCRIPTION
MTAs: BOTH SIDES NOW!. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/1.jpg)
MTAs: BOTH SIDES NOW!
![Page 2: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/2.jpg)
Marjorie Forster, Assistant Vice President, Research and Global Health Initiatives, University of Maryland Baltimore
M. Jeremy Trybulski, Consultant, formerly with the University of California, Office of the President
Melissa White, Contracts Manager, Merrimack Pharmaceuticals, Inc.
![Page 3: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/3.jpg)
3
AGENDA
• Steps to take prior to negotiation
• Standard MTA Definitions
• Mock Negotiation
• Take Home Messages
![Page 4: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/4.jpg)
4
Steps to take prior to negotiation: UNIVERSITY PERSPECTIVE
• CONFLICT CHECK– Would obligations to any other third party pose a conflict (i.e.
one that would prevent University’s grant of an exclusive option to inventions)?
• IP-Related Due Diligence – Pre-existing invention disclosures?– Background IP– Patents filed – Licenses
• Understanding of Research & Material (being sent out by Uni or received by Uni)
![Page 5: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/5.jpg)
5
Steps to take prior to negotiation: INDUSTRY PERSPECTIVE
• Research PI/UNI – Who is the PI/Lab? Have we worked with him/her before?– What papers has he/she published? – Who else in industry have they collaborated with in the past, or current industry
partners?
• IP Due Diligence – Pre-existing invention disclosures? – Patents filed– Background IP– Licenses
• Assess Outcomes/Deliverables– Any Modifications to the Material? – Likelihood of new IP?
• Potential Complications
![Page 6: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/6.jpg)
6
Steps to take prior to negotiation:Why is this important?
• Because you can’t (or shouldn’t) negotiate ANY contract without knowing the circumstances at hand! – More apt to miss something or split-up– RISK!
• Puts you in a better negotiating position!
![Page 7: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/7.jpg)
7
“STANDARD” MTA DEFINITIONS
• Material• Progeny• Unmodified Derivatives• Modifications• Confidential Information• Results• Inventions
![Page 8: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/8.jpg)
8
Material*
Original Material, as described herein, to include Progeny, Unmodified
Derivatives, and Confidential Information
* The definition CAN contain one or more of these elements, but not necessarily all
![Page 9: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/9.jpg)
9
Progeny
Unmodified descendants from the Material
![Page 10: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/10.jpg)
10
Unmodified Derivatives
Substances created by the Recipient in the course of the Research that
constitute an unmodified functional subunit or product expressed by the
Material
![Page 11: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/11.jpg)
11
Modifications
Substances developed by the Recipient in the course of the
Research that contain or incorporate the Material
![Page 12: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/12.jpg)
12
Confidential Information
Any information, know-how, and/or documentation related to the
Material that is provided by Provider to Recipient and is marked as
“confidential” by Provider
![Page 13: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/13.jpg)
13
Research Results
All research results created in the direct performance of the Research
defined in the Scope of Work
![Page 14: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/14.jpg)
14
Inventions
Any patentable invention that is conceived AND first reduced to
practice in the performance of the Research
![Page 15: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/15.jpg)
15
MOCK NEGOTIATION….
![Page 16: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/16.jpg)
16
TAKE HOME MESSAGES
• The more you know about the circumstances of the MTA and the Material, the better situated you are for negotiations
• Communication is essential to a negotiation - if industry proposes crazy changes, there’s likely (but not always) a reason why!!! Before spending time redlining another version, go back to your potential industry partner and inquire! Ask WHY changes were made to understand the REASON behind a change. It may change your outlook on negotiations…
![Page 17: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/17.jpg)
Questions?
![Page 18: MTAs: BOTH SIDES NOW!](https://reader036.vdocument.in/reader036/viewer/2022062305/568161a3550346895dd15c36/html5/thumbnails/18.jpg)
THANKS!